Novonesis Statistics

Total Valuation

Novonesis has a market cap or net worth of GBP 21.97 billion. The enterprise value is 23.28 billion.

Market Cap	21.97B
Enterprise Value	23.28B

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	Apr 4, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	346.96M

Valuation Ratios

The trailing PE ratio is 86.89.

PE Ratio	86.89
Forward PE	n/a
PS Ratio	6.93
PB Ratio	2.38
P/TBV Ratio	23.07
P/FCF Ratio	38.99
P/OCF Ratio	26.05
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.16, with an EV/FCF ratio of 41.29.

EV / Earnings	92.04
EV / Sales	7.08
EV / EBITDA	25.16
EV / EBIT	32.34
EV / FCF	41.29

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.16.

Current Ratio	1.73
Quick Ratio	1.05
Debt / Equity	0.16
Debt / EBITDA	1.66
Debt / FCF	2.64
Interest Coverage	10.48

Financial Efficiency

Return on equity (ROE) is 4.67% and return on invested capital (ROIC) is 6.61%.

Return on Equity (ROE)	4.67%
Return on Assets (ROA)	5.54%
Return on Invested Capital (ROIC)	6.61%
Return on Capital Employed (ROCE)	5.97%
Revenue Per Employee	299,583
Profits Per Employee	23,898
Employee Count	10,582
Asset Turnover	0.40
Inventory Turnover	3.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.18% in the last 52 weeks. The beta is 0.56, so Novonesis's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+6.18%
50-Day Moving Average	407.13
200-Day Moving Average	425.98
Relative Strength Index (RSI)	52.88
Average Volume (20 Days)	402,782

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novonesis had revenue of GBP 3.17 billion and earned 252.89 million in profits. Earnings per share was 0.91.

Revenue	3.17B
Gross Profit	1.65B
Operating Income	697.05M
Pretax Income	344.93M
Net Income	252.89M
EBITDA	894.95M
EBIT	697.05M
Earnings Per Share (EPS)	0.91

Full Income Statement

Balance Sheet

The company has 231.55 million in cash and 1.49 billion in debt, giving a net cash position of -1.25 billion.

Cash & Cash Equivalents	231.55M
Total Debt	1.49B
Net Cash	-1.25B
Net Cash Per Share	n/a
Equity (Book Value)	9.24B
Book Value Per Share	33.26
Working Capital	654.22M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 843.43 million and capital expenditures -279.76 million, giving a free cash flow of 563.66 million.

Operating Cash Flow	843.43M
Capital Expenditures	-279.76M
Free Cash Flow	563.66M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.00%, with operating and profit margins of 21.99% and 7.98%.

Gross Margin	52.00%
Operating Margin	21.99%
Pretax Margin	10.88%
Profit Margin	7.98%
EBITDA Margin	28.23%
EBIT Margin	21.99%
FCF Margin	17.78%

Dividends & Yields

This stock pays an annual dividend of 0.70, which amounts to a dividend yield of 0.17%.

Dividend Per Share	0.70
Dividend Yield	0.17%
Dividend Growth (YoY)	-1.72%
Years of Dividend Growth	n/a
Payout Ratio	81.65%
Buyback Yield	-0.64%
Shareholder Yield	-0.47%
Earnings Yield	1.15%
FCF Yield	2.57%

Dividend Details

Stock Splits

The last stock split was on November 28, 2011. It was a forward split with a ratio of 5.

Last Split Date	Nov 28, 2011
Split Type	Forward
Split Ratio	5

Scores

Novonesis has an Altman Z-Score of 5.27.

Altman Z-Score	5.27
Piotroski F-Score	n/a